AICAR is a compound that has garnered significant attention in recent years due to its potential applications in sports, medicine, and metabolism. This article delves into the various uses of AICAR, exploring its effects on athletic performance, medical benefits, and its role in fat loss and metabolic regulation.
Product Code: BM-2-4-137
CAS number:2627-69-2
Molecular formula: C9H14N4O5
Molecular weight: 258.23
EINECS number: 220-097-5
MDL No.: MFCD00869751
Hs code: 29349990
Analysis items: HPLC>99.0%, LC-MS
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Manufacturer: BLOOM TECH Changzhou Factory
Technology service: R&D Dept.-4
We provide AICAR, please refer to the following website for detailed specifications and product information.
Product:https://www.bloomtechz.com/synthetic-chemical/peptide/aicar-powder-cas-2627-69-2.html
AICAR in Sports: Performance and Endurance Boost
In the world of sports and athletics, AICAR has emerged as a subject of intense interest due to its potential to enhance performance and endurance. Athletes and researchers alike have been intrigued by the compound's ability to mimic the effects of exercise at a cellular level.
AICAR activates AMP-activated protein kinase (AMPK), an enzyme that plays a crucial role in cellular energy homeostasis. This activation simulates some of the physiological adaptations typically associated with endurance exercise, even in the absence of physical activity. As a result, the product has been dubbed "exercise in a pill" by some enthusiasts.
Studies have shown that AICAR can increase endurance capacity in animal models. In one notable experiment, sedentary mice treated with the product were able to run 44% longer than untreated mice. This remarkable improvement in endurance without actual training has led to speculation about AICAR's potential as a performance-enhancing substance in competitive sports.
However, it's important to note that the use of AICAR as a performance enhancer is prohibited by the World Anti-Doping Agency (WADA). The agency added the product to its list of banned substances in 2009, categorizing it under "hormone and metabolic modulators." Despite this ban, the compound continues to be a topic of discussion and research in sports science circles.
While the potential benefits of AICAR in sports performance are intriguing, it's crucial to approach these findings with caution. The long-term effects of the product use in humans are not yet fully understood, and more research is needed to determine its safety and efficacy as a performance-enhancing agent.
Medical Uses of AICAR: Potential Benefits and Risks
Beyond its applications in sports, AICAR has shown promise in various medical fields. Researchers are exploring its potential therapeutic uses for a range of conditions, from metabolic disorders to cardiovascular diseases.
One of the most promising areas of AICAR research is in the treatment of metabolic syndrome. This cluster of conditions, including high blood pressure, high blood sugar, excess body fat around the waist, and abnormal cholesterol levels, increases the risk of heart disease, stroke, and type 2 diabetes. AICAR's ability to activate AMPK could potentially help regulate these metabolic processes, offering a new approach to managing this complex condition.
In cardiovascular health, AICAR has shown potential in protecting against ischemia-reperfusion injury, a type of tissue damage caused when blood supply returns to tissue after a period of lack of oxygen. This could have implications for treating heart attacks and strokes, where quick restoration of blood flow is crucial but can paradoxically cause additional damage.
AICAR has also been studied for its potential neuroprotective effects. Some research suggests it could help protect brain cells from damage and death, which could be beneficial in treating neurodegenerative diseases like Alzheimer's and Parkinson's.
However, as with any potential medical treatment, AICAR comes with its own set of risks and potential side effects. Some studies have reported adverse effects such as:
Hypoglycemia (low blood sugar)
Lactic acidosis (buildup of lactic acid in the body)
Gastrointestinal discomfort
Potential impact on liver function
It's crucial to note that most of the research on AICAR's medical applications has been conducted in laboratory settings or animal models. Human trials are still limited, and more extensive research is needed to fully understand the compound's effects, optimal dosing, and potential long-term consequences.
As with any medical treatment, the use of AICAR should only be considered under the guidance of a healthcare professional. Self-administration or unsupervised use of it can be dangerous and is not recommended.
AICAR and Fat Loss: How It Affects Metabolism
One of the most intriguing aspects of AICAR is its potential role in fat loss and metabolic regulation. The compound's ability to activate AMPK has significant implications for how the body processes and stores fat.
AMPK activation by AICAR leads to several metabolic changes that can contribute to fat loss:
Increased fatty acid oxidation:
AICAR stimulates the breakdown of fatty acids for energy, potentially reducing fat stores in the body.
Improved glucose uptake:
By enhancing the body's ability to take up glucose from the bloodstream, it can help regulate blood sugar levels and potentially reduce fat storage.
Mitochondrial biogenesis:
AICAR promotes the creation of new mitochondria, the powerhouses of cells, which can increase overall metabolic rate.
Reduced lipogenesis:
AICAR inhibits the synthesis of new fatty acids, potentially preventing the accumulation of new fat deposits.
These metabolic effects have led researchers to investigate AICAR as a potential treatment for obesity and related metabolic disorders. In animal studies, AICAR administration has been shown to reduce body weight and improve insulin sensitivity, two key factors in metabolic health.
However, it's important to note that the effects of AICAR on human metabolism and fat loss are still being studied. While animal studies have shown promising results, human trials are limited, and the long-term effects of it use for fat loss are not yet fully understood.
Moreover, AICAR is not a magic solution for weight loss. Its effects are most pronounced when combined with a balanced diet and regular exercise. In fact, some researchers suggest that it might be most beneficial in enhancing the metabolic benefits of exercise, rather than as a standalone treatment for obesity.
It's also worth noting that AICAR's effects on metabolism can vary depending on the individual's current metabolic state. For example, its impact on glucose uptake may be more pronounced in individuals with insulin resistance compared to those with normal insulin sensitivity.
While the potential of AICAR in fat loss and metabolic regulation is exciting, it's crucial to approach these findings with caution. More research is needed to fully understand how it affects human metabolism and to determine safe and effective protocols for its use in weight management.
As with any compound that affects metabolism, the use of AICAR for fat loss should only be considered under the guidance of a healthcare professional. Unsupervised use can lead to potential health risks and may not produce the desired results.
In conclusion, AICAR represents a fascinating area of research in sports science, medicine, and metabolism. Its ability to mimic some of the effects of exercise at a cellular level opens up intriguing possibilities for enhancing athletic performance, treating metabolic disorders, and aiding in fat loss. However, it's crucial to remember that much of the research on it is still in its early stages, particularly when it comes to its effects on humans.
As research continues, we may gain a clearer understanding of AICAR's potential benefits and risks, paving the way for new treatments and applications. Until then, it's important to approach claims about it with a critical eye and to prioritize evidence-based, professionally guided approaches to health and fitness.
If you're interested in learning more about AICAR and its potential applications, we encourage you to stay informed about the latest research developments. For any inquiries about AICAR or related compounds, please don't hesitate to reach out to us at Sales@bloomtechz.com. Our team of experts is always ready to provide you with the most up-to-date information and guidance.
References
Narkar, V. A., et al. (2008). AMPK and PPARδ agonists are exercise mimetics. Cell, 134(3), 405-415.
Merrill, G. F., et al. (1997). AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. American Journal of Physiology, 273(6), E1107-E1112.
Coughlan, K. A., et al. (2014). AMPK activation: a therapeutic target for type 2 diabetes? Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 7, 241-253.
Buhl, E. S., et al. (2002). Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes, 51(7), 2199-2206.